참고문헌 (25)

1. CA-Cancer J Clin RL Siegel 68 1 7 2018 10.3322/caac.21442 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA-Cancer J Clin. 2018;68(1):7-30. https://doi.org/10.3322/caac.21442. 

   상세보기

2. Nat Chem Biol PH Cha 12 8 593 2016 10.1038/nchembio.2103 Cha PH, Cho YH, Lee SK, Lee J, Jeong WJ, Moon BS, et al. Small-molecule binding of the axin RGS domain promotes beta-catenin and Ras degradation. Nat Chem Biol. 2016;12(8):593-600. https://doi.org/10.1038/nchembio.2103. 

   상세보기

3. J Natl Cancer Inst. BS Moon 106 2 djt373 2014 10.1093/jnci/djt373 Moon BS, Jeong WJ, Park J, Kim TI, Min-do S, Choi KY. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/beta-catenin signaling. J Natl Cancer Inst. 2014;106(2):djt373. https://doi.org/10.1093/jnci/djt373. 

   상세보기

4. Gastroenterol KP Janssen 131 4 1096 2006 10.1053/j.gastro.2006.08.011 Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterol. 2006;131(4):1096-109. https://doi.org/10.1053/j.gastro.2006.08.011. 

   상세보기

5. Gastroenterology Y Feng 141 3 1003-13e1 2011 10.1053/j.gastro.2011.05.007 Feng Y, Bommer GT, Zhao J, Green M, Sands E, Zhai Y, et al. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology. 2011;141(3):1003-13e1-1003-13e10. https://doi.org/10.1053/j.gastro.2011.05.007. 

   상세보기

6. Cancer Res J Yoon 71 2 445 2011 10.1158/0008-5472.CAN-10-3058 Yoon J, Koo KH, Choi KY. MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy. Cancer Res. 2011;71(2):445-53. https://doi.org/10.1158/0008-5472.CAN-10-3058. 

   상세보기

7. Science J Yun 325 5947 1555 2009 10.1126/science.1174229 Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325(5947):1555-9. https://doi.org/10.1126/science.1174229. 

   상세보기

8. Sci Signal. WJ Jeong 5 219 ra30 2012 10.1126/scisignal.2002242 Jeong WJ, Yoon J, Park JC, Lee SH, Kaduwal S, Kim H, et al. Ras stabilization through aberrant activation of Wnt/beta-catenin signaling promotes intestinal tumorigenesis. Sci Signal. 2012;5(219):ra30. https://doi.org/10.1126/scisignal.2002242. 

   상세보기

9. Oncotarget. KH Koo 6 25 21328 2015 10.18632/oncotarget.4049 Koo KH, Jeong WJ, Cho YH, Park JC, Min do S, Choi KY. K-Ras stabilization by estrogen via PKCdelta is involved in endometrial tumorigenesis. Oncotarget. 2015;6(25):21328-40. https://doi.org/10.18632/oncotarget.4049. 

   상세보기

10. EMBO Rep. SK Lee 2018 10.15252/embr.201846060 Lee SK, Jeong WJ, Cho YH, Cha PH, Yoon JS, Ro EJ, et al. beta-Catenin-RAS interaction serves as a molecular switch for RAS degradation via GSK3beta. EMBO Rep. 2018. https://doi.org/10.15252/embr.201846060. 

    상세보기

11. J Biol Chem SH Jeon 282 19 14482 2007 10.1074/jbc.M611129200 Jeon SH, Yoon JY, Park YN, Jeong WJ, Kim S, Jho EH, et al. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin. J Biol Chem. 2007;282(19):14482-92. https://doi.org/10.1074/jbc.M611129200. 

    상세보기

12. J Cell Sci KS Park 119 Pt 5 819 2006 10.1242/jcs.02779 Park KS, Jeon SH, Kim SE, Bahk YY, Holmen SL, Williams BO, et al. APC inhibits ERK pathway activation and cellular proliferation induced by RAS. J Cell Sci. 2006;119(Pt 5):819-27. https://doi.org/10.1242/jcs.02779. 

    상세보기

13. Curr Med Chem T Efferth 19 33 5735 2012 10.2174/092986712803988884 Efferth T. Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules. Curr Med Chem. 2012;19(33):5735-44. 

    상세보기

14. BMC Cancer MG Dozmorov 10 672 2010 10.1186/1471-2407-10-672 Dozmorov MG, Azzarello JT, Wren JD, Fung KM, Yang Q, Davis JS, et al. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression. BMC Cancer. 2010;10:672. https://doi.org/10.1186/1471-2407-10-672. 

    상세보기

15. Clin Cancer Res L Song 17 7 1839 2011 10.1158/1078-0432.CCR-10-0720 Song L, Xiong H, Li J, Liao W, Wang L, Wu J, et al. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-kappaB pathway in human non-small cell lung cancer. Clin Cancer Res. 2011;17(7):1839-49. https://doi.org/10.1158/1078-0432.CCR-10-0720. 

    상세보기

16. Int J Oncol M Jiao 40 2 461 2012 10.3892/ijo.2011.1197 Jiao M, Nan KJ. Activation of PI3 kinase/Akt/HIF-1alpha pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. Int J Oncol. 2012;40(2):461-8. https://doi.org/10.3892/ijo.2011.1197. 

    상세보기

17. Genes Dev LC Vredeveld 26 10 1055 2012 10.1101/gad.187252.112 Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM, et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012;26(10):1055-69. https://doi.org/10.1101/gad.187252.112. 

    상세보기

18. J Biosci D Wang 37 1 91 2012 10.1007/s12038-011-9172-4 Wang D, Chen J, Chen H, Duan Z, Xu Q, Wei M, et al. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway. J Biosci. 2012;37(1):91-101. 

    상세보기

19. Gene Chromosome Canc M Christgen 52 1 69 2013 10.1002/gcc.22007 Christgen M, Noskowicz M, Schipper E, Christgen H, Heil C, Krech T, et al. Oncogenic PIK3CA mutations in lobular breast cancer progression. Gene Chromosome Canc. 2013;52(1):69-80. https://doi.org/10.1002/gcc.22007. 

    상세보기

20. Ann Clin Lab Sci Z Zhuang 41 4 364 2011 Zhuang Z, Zhao X, Wu Y, Huang R, Zhu L, Zhang Y, et al. The anti-apoptotic effect of PI3K-Akt signaling pathway after subarachnoid hemorrhage in rats. Ann Clin Lab Sci. 2011;41(4):364-72. 

    상세보기

21. Br J Cancer K Malinowsky 110 8 2081 2014 10.1038/bjc.2014.100 Malinowsky K, Nitsche U, Janssen KP, Bader FG, Spath C, Drecoll E, et al. Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br J Cancer. 2014;110(8):2081-9. https://doi.org/10.1038/bjc.2014.100. 

    상세보기

22. J Cell Biochem A Bahrami 119 3 2460 2018 10.1002/jcb.25950 Bahrami A, Khazaei M, Hasanzadeh M, ShahidSales S, Joudi Mashhad M, Farazestanian M, et al. Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress. J Cell Biochem. 2018;119(3):2460-9. https://doi.org/10.1002/jcb.25950. 

    상세보기

23. Gastroenterol J Zhang 141 1 50 2011 10.1053/j.gastro.2011.05.010 Zhang J, Roberts TM, Shivdasani RA. Targeting PI3K signaling as a therapeutic approach for colorectal cancer. Gastroenterol. 2011;141(1):50-61. https://doi.org/10.1053/j.gastro.2011.05.010. 

    상세보기

24. OncoTargets Ther Z Jiang 12 509 2019 10.2147/OTT.S187817 Jiang Z, Cao Q, Dai G, Wang J, Liu C, Lv L, et al. Celastrol inhibits colorectal cancer through TGF-beta1/Smad signaling. OncoTargets Ther. 2019;12:509-18. https://doi.org/10.2147/OTT.S187817. 

    상세보기

25. Genes Dev X Guo 22 1 106 2008 10.1101/gad.1590908 Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev. 2008;22(1):106-20. https://doi.org/10.1101/gad.1590908. 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.